Cell Type

PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

The Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace, NOT-MH-21-125, encourages the translation of BRAIN Initiative-supported technologies from academic and other non-small business research sectors to the marketplace.

PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

The Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace, NOT-MH-21-125, encourages the translation of BRAIN Initiative-supported technologies from academic and other non-small business research sectors to the marketplace.

Addgene Launches Open Access Recombinant Antibody Resource for the Scientific Research Community

Addgene, the nonprofit biorepository, now produces and distributes ready-to-use recombinant antibodies. The inaugural collection of monoclonal antibodies is part of the Neuroscience AntiBody Open Resource (NABOR), a platform that provides open access to recombinant antibodies and affinity reagents for the neuroscience community. NABOR is supported by a grant from the National Institutes of Health’s Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.

Labroots Neuroscience Virtual Conference

Labroots is excited to present the 10th Annual Neuroscience Virtual Conference, to be broadcasted live on March 10th, 2022.  This distinguished, online-only, event is free to attend and will once again bring together the neuroscience community to discuss and present the newest advances in understanding the human brain, neuropsychiatric disorders, and behavioral processes as it relates to the brain function.